13F

Stock

Tarsus Pharmaceuticals, Inc.

TARS · held by 9 managers

Reported value

$151.4M

Holders

9

+1 new · −0 exited

Holders’ est. mark

$1.74M

Price effect on 3 books still in the name

Largest holder

$113.7M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY1.91M$113.7MHeld
BANK OF AMERICA CORP /DE/536K$31.9MHeld
BARCLAYS PLC92.1K$5.48M$1.74MAdded$306.8K
Leonteq Securities AG6.5K$386.3KNew
Allworth Financial LP33$1.96KHeld
Essential Partners LLC26$1.54K$56Added$1.42K
Catherine Avery Investment Management LLC10$594$189Cut−$216
KBC Group NV1.3K$77Held
IFP Advisors, Inc1$59Held

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.